{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:51:53Z","timestamp":1792792313250,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mucopolysaccharidosis (MPS) type IIIB is the progressive degeneration of the central nervous system. Resveratrol is proposed as a potential therapeutic molecule as a drug reducing inflammation and for improving behavior of MPS mice. Here we investigated autophagy in correlation with immune response in an MPS IIIB mouse model. The effects of resveratrol on mouse behavior and the levels of selected cytokines that influence the inflammation were assessed. The study was performed on both male and female mice treated or not with resveratrol. The results of behavioral, molecular and biochemical experiments confirmed that autophagy and immune response are disturbed in MPS IIIB mice. A correlation between behavioral disturbances and levels of heparan sulfate and TLR4 could be observed. The FOXO3 transcription factor was identified as one of the key factors in the resveratrol-mediated stimulation of the autophagy process in the MPS IIIB mouse model, though it was not the sole pathway induced by this compound. We conclude that resveratrol can modulate the degradation of glycosaminoglycans and also may contribute to the reduction of inflammation and the normalization of animal behavior in the MPS IIIB model.<\/jats:p>","DOI":"10.1038\/s12276-026-01643-0","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:49:41Z","timestamp":1770263381000},"page":"436-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["TFEB, FOXO3 and TLR4 in resveratrol-induced autophagy in a mucopolysaccharidosis IIIB mouse model"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-766X","authenticated-orcid":false,"given":"Estera","family":"Rintz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Podlacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Gaffke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Jerzemowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Cyske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Pierzynowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"1643_CR1","first-page":"1113","volume":"25","author":"S Tomatsu","year":"2018","unstructured":"Tomatsu, S. et al. Mucopolysaccharidoses update (2 volume set). Nova Sci. Publ. 25, 1113 (2018).","journal-title":"Nova Sci. Publ."},{"key":"1643_CR2","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3390\/diagnostics14161734","volume":"14","author":"K Wi\u015bniewska","year":"2024","unstructured":"Wi\u015bniewska, K. et al. Mucopolysaccharidosis type IIIE: a real human disease or a diagnostic pitfall?. Diagnostics 14, 1734 (2024).","journal-title":"Diagnostics"},{"key":"1643_CR3","doi-asserted-by":"publisher","first-page":"9570","DOI":"10.3390\/ijms25179570","volume":"25","author":"Z Cyske","year":"2024","unstructured":"Cyske, Z., Gaffke, L., Pierzynowska, K. & W\u0119grzyn, G. Mucopolysaccharidosis-plus syndrome: is this a type of mucopolysaccharidosis or a separate kind of metabolic disease?. Int. J. Mol. Sci. 25, 9570 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1643_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13052-018-0559-9","volume":"44","author":"A Del Longo","year":"2018","unstructured":"Del Longo, A., Piozzi, E. & Schweizer, F. Ocular features in mucopolysaccharidosis: diagnosis and treatment. Ital. J. Pediatr. 44, 125 (2018).","journal-title":"Ital. J. Pediatr."},{"key":"1643_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2024.06.011","volume":"122","author":"SA Khan","year":"2024","unstructured":"Khan, S. A. et al. Glycosaminoglycans in mucopolysaccharidoses and other disorders. Adv. Clin. Chem. 122, 1\u201352 (2024).","journal-title":"Adv. Clin. Chem."},{"key":"1643_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5582\/irdr.2020.01011","volume":"9","author":"J Zhou","year":"2020","unstructured":"Zhou, J., Lin, J., Leung, W. T. & Wang, L. A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management. Intractable Rare Dis. Res. 9, 1\u20139 (2020).","journal-title":"Intractable Rare Dis. Res."},{"key":"1643_CR7","doi-asserted-by":"publisher","first-page":"108507","DOI":"10.1016\/j.ymgme.2024.108507","volume":"142","author":"E Rintz","year":"2024","unstructured":"Rintz, E., Banacki, M., Ziemian, M., Kobus, B. & Wegrzyn, G. Causes of death in mucopolysaccharidoses. Mol. Genet. Metab. 142, 108507 (2024).","journal-title":"Mol. Genet. Metab."},{"key":"1643_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/ped.12636","volume":"57","author":"F Andrade","year":"2015","unstructured":"Andrade, F., Ald\u00e1miz-Echevarr\u00eda, L., Llarena, M. & Couce, M. L. Sanfilippo syndrome: overall review. Pediatr. Int. 57, 331\u2013338 (2015).","journal-title":"Pediatr. Int."},{"key":"1643_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/apa.12169","volume":"102","author":"FA Wijburg","year":"2013","unstructured":"Wijburg, F. A., W\u0119grzyn, G., Burton, B. K. & Tylki-Szyma\u0144ska, A. Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit\/hyperactivity disorder or autism spectrum disorder. Acta Paediatr. 102, 462\u2013470 (2013).","journal-title":"Acta Paediatr."},{"key":"1643_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-43","volume":"6","author":"MJ Valstar","year":"2011","unstructured":"Valstar, M. J., Marchal, J. P., Grootenhuis, M., Colland, V. & Wijburg, F. A. Cognitive development in patients with mucopolysaccharidosis type III (Sanfilippo syndrome). Orphanet J. Rare Dis. 6, 43 (2011).","journal-title":"Orphanet J. Rare Dis."},{"key":"1643_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10545-012-9572-0","volume":"36","author":"EM Cross","year":"2013","unstructured":"Cross, E. M. & Hare, D. J. Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders. J. Inherit. Metab. Dis. 36, 189\u2013200 (2013).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1643_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3174\/ajnr.A2832","volume":"34","author":"DI Zafeiriou","year":"2013","unstructured":"Zafeiriou, D. I. & Batzios, S. P. Brain and spinal MR imaging findings in mucopolysaccharidoses: a review. Am J. Neuroradiol. 34, 5\u201313 (2013).","journal-title":"Am J. Neuroradiol."},{"key":"1643_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1232-0","volume":"14","author":"S Nijmeijer","year":"2019","unstructured":"Nijmeijer, S. et al. The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype. Orphanet J. Rare Dis. 14, 249 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"1643_CR14","doi-asserted-by":"publisher","first-page":"173562","DOI":"10.1016\/j.ejphar.2020.173562","volume":"888","author":"W Kong","year":"2020","unstructured":"Kong, W. et al. Update of treatment for mucopolysaccharidosis type III (Sanfilippo syndrome). Eur. J. Pharmacol. 888, 173562 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"1643_CR15","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.3390\/ijms21082975","volume":"21","author":"R Parini","year":"2020","unstructured":"Parini, R. & Deodato, F. Intravenous enzyme replacement therapy in mucopolysaccharidoses: clinical effectiveness and limitations. Int. J. Mol. Sci. 21, 2975 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1643_CR16","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","volume":"25","author":"M Taylor","year":"2019","unstructured":"Taylor, M. et al. Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future. Biol. Blood Marrow Transplant. 25, e226\u2013e246 (2019).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"1643_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.expneurol.2010.07.024","volume":"225","author":"AA Lau","year":"2010","unstructured":"Lau, A. A. et al. Allogeneic stem cell transplantation does not improve neurological deficits in mucopolysaccharidosis type IIIA mice. Exp. Neurol. 225, 445\u2013454 (2010).","journal-title":"Exp. Neurol."},{"key":"1643_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1023\/A:1005526628598","volume":"22","author":"P Sivakumur","year":"1999","unstructured":"Sivakumur, P. & Wraith, J. E. Bone marrow transplantation in mucopolysaccharidosis type IIIA: a comparison of an early treated patient with his untreated sibling. J. Inherit. Metab. Dis. 22, 849\u2013850 (1999).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1643_CR19","first-page":"100578","volume":"23","author":"AF K\u00f6hn","year":"2020","unstructured":"K\u00f6hn, A. F. et al. Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: a case description and comparison with a genotype-matched control group. Mol. Genet. Metab. Rep. 23, 100578 (2020).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"1643_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/jnc.14632","volume":"148","author":"H Parker","year":"2019","unstructured":"Parker, H. & Bigger, B. W. The role of innate immunity in mucopolysaccharide diseases. J. Neurochem. 148, 639\u2013651 (2019).","journal-title":"J. Neurochem."},{"key":"1643_CR21","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1182\/blood-2011-07-368720","volume":"120","author":"TV Brennan","year":"2012","unstructured":"Brennan, T. V. et al. Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. Blood 120, 2899\u20132908 (2012).","journal-title":"Blood"},{"key":"1643_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-219","volume":"9","author":"H Akbarshahi","year":"2011","unstructured":"Akbarshahi, H. et al. TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated. J. Transl. Med. 9, 219 (2011).","journal-title":"J. Transl. Med."},{"key":"1643_CR23","doi-asserted-by":"publisher","first-page":"863667","DOI":"10.3389\/fphar.2022.863667","volume":"13","author":"AM Wiesinger","year":"2022","unstructured":"Wiesinger, A. M. et al. The inflammation in the cytopathology of patients with mucopolysaccharidoses\u2014immunomodulatory drugs as an approach to therapy. Front. Pharmacol. 13, 863667 (2022).","journal-title":"Front. Pharmacol."},{"key":"1643_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1572-5995(03)80149-7","volume":"28","author":"Y Kimura","year":"2003","unstructured":"Kimura, Y. Prevention of cancer chemotherapy drug-induced adverse reaction, antitumor and antimetastatic activities by natural products. Stud. Nat. Prod. Chem. 28, 559\u2013586 (2003).","journal-title":"Stud. Nat. Prod. Chem."},{"key":"1643_CR25","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.3390\/nu14173519","volume":"14","author":"AD Inchingolo","year":"2022","unstructured":"Inchingolo, A. D. et al. Effects of resveratrol, curcumin and quercetin supplementation on bone metabolism\u2014a systematic review. Nutrients 14, 3519 (2022).","journal-title":"Nutrients"},{"key":"1643_CR26","first-page":"1675","volume":"8","author":"F Zahedipour","year":"2022","unstructured":"Zahedipour, F., Hosseini, S. A., Henney, N. C., Barreto, G. E. & Sahebkar, A. Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases. Neural Regen. Res. 8, 1675\u20131684 (2022).","journal-title":"Neural Regen. Res."},{"key":"1643_CR27","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3390\/ijms21041453","volume":"21","author":"LM Martin","year":"2020","unstructured":"Martin, L. M., Johnson, P. J., Amorim, J. R. & DeClue, A. E. Effects of orally administered resveratrol on TNF, IL-1\u03b2, leukocyte phagocytic activity and oxidative burst function in horses. Int. J. Mol. Sci. 21, 1453 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1643_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/molecules26010229","volume":"26","author":"T Meng","year":"2021","unstructured":"Meng, T. et al. Anti-inflammatory action and mechanisms of resveratrol. Molecules 26, 229 (2021).","journal-title":"Molecules"},{"key":"1643_CR29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/nu11050946","volume":"11","author":"L Malaguarnera","year":"2019","unstructured":"Malaguarnera, L. Influence of resveratrol on the immune response. Nutrients 11, 946 (2019).","journal-title":"Nutrients"},{"key":"1643_CR30","doi-asserted-by":"publisher","first-page":"942","DOI":"10.7150\/ijms.16810","volume":"13","author":"D Xu","year":"2016","unstructured":"Xu, D. et al. Resveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in rats. Int. J. Med. Sci. 13, 942\u2013954 (2016).","journal-title":"Int. J. Med. Sci."},{"key":"1643_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12017-019-08559-1","volume":"22","author":"K Pierzynowska","year":"2020","unstructured":"Pierzynowska, K., Gaffke, L., Podlacha, M. & Wegrzyn, G. Mucopolysaccharidosis and autophagy: controversies on the contribution of the process to the pathogenesis and possible therapeutic applications. Neuromol. Med. 22, 25\u201330 (2020).","journal-title":"Neuromol. Med."},{"key":"1643_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13311-022-01323-7","volume":"20","author":"E Rintz","year":"2023","unstructured":"Rintz, E. et al. Activities of (poly)phenolic antioxidants and other natural autophagy modulators in the treatment of sanfilippo disease: remarkable efficacy of resveratrol in cellular and animal models. Neurotherapeutics 20, 254\u2013271 (2023).","journal-title":"Neurotherapeutics"},{"key":"1643_CR33","first-page":"622","volume":"53","author":"SI Gografe","year":"2003","unstructured":"Gografe, S. I. et al. Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain. Comp. Med. 53, 622\u2013632 (2003).","journal-title":"Comp. Med."},{"key":"1643_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0006-8993(02)03543-6","volume":"958","author":"Q Wang","year":"2002","unstructured":"Wang, Q. et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 958, 439\u2013447 (2002).","journal-title":"Brain Res."},{"key":"1643_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","volume":"1215","author":"T Walle","year":"2011","unstructured":"Walle, T. Bioavailability of resveratrol. Ann. N. Y. Acad. Sci. 1215, 9\u201315 (2011).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1643_CR36","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1158\/0008-5472.CAN-10-2027","volume":"70","author":"Patel","year":"2010","unstructured":"Patel et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 70, 7392\u20137399 (2010).","journal-title":"Cancer Res."},{"key":"1643_CR37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jpba.2009.03.014","volume":"51","author":"I Rodr\u00edguez-Meizoso","year":"2010","unstructured":"Rodr\u00edguez-Meizoso, I. et al. Subcritical water extraction and characterization of bioactive compounds from Haematococcus pluvialis microalga. J. Pharm. Biomed. Anal. 51, 456\u2013463 (2010).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"1643_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/liv.12893","volume":"36","author":"SK Das","year":"2016","unstructured":"Das, S. K., DesAulniers, J., Dyck, J. R., Kassiri, Z. & Oudit, G. Y. Resveratrol mediates therapeutic hepatic effects in acquired and genetic murine models of iron-overload. Liver Int. 36, 246\u2013257 (2016).","journal-title":"Liver Int."},{"key":"1643_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1139\/apnm-2019-0057","volume":"45","author":"Huang","year":"2020","unstructured":"Huang et al. Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPAR\u03b1 pathway. Appl. Physiol. Nutr. Metab. 45, 227\u2013239 (2020).","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"1643_CR40","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1113\/JP278082","volume":"597","author":"Brawerman","year":"2019","unstructured":"Brawerman et al. Maternal resveratrol administration protects against gestational diabetes-induced glucose intolerance and islet dysfunction in the rat offspring. J. Physiol. 597, 4175\u20134192 (2019).","journal-title":"J. Physiol."},{"key":"1643_CR41","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/mnfr.201100143","volume":"55","author":"JM Smoliga","year":"2011","unstructured":"Smoliga, J. M., Baur, J. A. & Hausenblas, H. A. Resveratrol and health\u2014a comprehensive review of human clinical trials. Mol. Nutr. Food Res. 55, 1129\u20131141 (2011).","journal-title":"Mol. Nutr. Food Res."},{"key":"1643_CR42","doi-asserted-by":"publisher","first-page":"e0183426","DOI":"10.1371\/journal.pone.0183426","volume":"12","author":"Z Ma","year":"2017","unstructured":"Ma, Z. et al. Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1\u03b1 expression and mitochondrial ROS production. PLoS ONE 12, e0183426 (2017).","journal-title":"PLoS ONE"},{"key":"1643_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.fct.2012.10.026","volume":"52","author":"P Xin","year":"2013","unstructured":"Xin, P. et al. Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with upregulation of hepatic LDL receptor and scavenger receptor class B type I gene expressions in rats. Food Chem. Toxicol. 52, 12\u201318 (2013).","journal-title":"Food Chem. Toxicol."},{"key":"1643_CR44","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1007\/s12035-018-1157-y","volume":"56","author":"R Corpas","year":"2019","unstructured":"Corpas, R., Gri\u00f1\u00e1n-Ferr\u00e9, C., Rodr\u00edguez-Farr\u00e9, E., Pall\u00e0s, M. & Sanfeliu, C. Resveratrol induces brain resilience against Alzheimer neurodegeneration through proteostasis enhancement. Mol. Neurobiol. 56, 1502\u20131516 (2019).","journal-title":"Mol. Neurobiol."},{"key":"1643_CR45","doi-asserted-by":"publisher","first-page":"8051870","DOI":"10.1155\/2017\/8051870","volume":"2017","author":"A Wagnerova","year":"2017","unstructured":"Wagnerova, A. et al. Sex differences in the effect of resveratrol on DSS-induced colitis in mice. Gastroenterol. Res. Pract. 2017, 8051870 (2017).","journal-title":"Gastroenterol. Res. Pract."},{"key":"1643_CR46","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","volume":"85","author":"RS Turner","year":"2015","unstructured":"Turner, R. S. et al. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85, 1383\u20131391 (2015).","journal-title":"Neurology"},{"key":"1643_CR47","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1080\/15548627.2023.2286116","volume":"20","author":"K Pierzynowska","year":"2024","unstructured":"Pierzynowska, K. et al. Correction of symptoms of Huntington disease by genistein through FOXO3-mediated autophagy stimulation. Autophagy 20, 1159\u20131182 (2024).","journal-title":"Autophagy"},{"key":"1643_CR48","doi-asserted-by":"publisher","first-page":"116467","DOI":"10.1016\/j.bcp.2024.116467","volume":"229","author":"E Rintz","year":"2024","unstructured":"Rintz, E. et al. Synergistic effects of resveratrol and enzyme replacement therapy in the mucopolysaccharidosis type I. Biochem. Pharmacol. 229, 116467 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"1643_CR49","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ymgme.2018.08.003","volume":"125","author":"BW Bigger","year":"2018","unstructured":"Bigger, B. W., Begley, D. J., Virgintino, D. & Pshezhetsky, A. V. Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disorders. Mol. Genet. Metab. 125, 322\u2013331 (2018).","journal-title":"Mol. Genet. Metab."},{"key":"1643_CR50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jpeds.2018.01.044","volume":"197","author":"CB Whitley","year":"2018","unstructured":"Whitley, C. B. et al. Observational prospective natural history of patients with Sanfilippo syndrome type B. J. Pediatr. 197, 198\u2013206.e2 (2018).","journal-title":"J. Pediatr."},{"key":"1643_CR51","doi-asserted-by":"publisher","first-page":"1795\u2013","DOI":"10.1007\/s00787-025-02661-5","volume":"34","author":"K Wi\u015bniewska","year":"2025","unstructured":"Wi\u015bniewska, K. et al. Behavioural disorders and sleep problems in Sanfilippo syndrome: overlaps with some other conditions and importance indications. Eur. Child Adolesc. Psychiatry 34, 1795\u20131816 (2025).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"1643_CR52","doi-asserted-by":"publisher","first-page":"14505","DOI":"10.1073\/pnas.96.25.14505","volume":"96","author":"Li","year":"1999","unstructured":"Li et al. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc. Natl Acad. Sci. USA 96, 14505\u201314510 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1643_CR53","doi-asserted-by":"publisher","first-page":"e14192","DOI":"10.1371\/journal.pone.0014192","volume":"5","author":"M Malinowska","year":"2010","unstructured":"Malinowska, M. et al. Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS ONE 5, e14192 (2010).","journal-title":"PLoS ONE"},{"key":"1643_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.652310","volume":"9","author":"YQ Li","year":"2021","unstructured":"Li, Y. Q. et al. An inhibitor of NF-\u03baB and an agonist of AMPK: network prediction and multi-omics integration to derive signaling pathways for acteoside against Alzheimer\u2019s disease. Front. Cell Dev. Biol. 9, 652310 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1643_CR55","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/cells13201690","volume":"13","author":"MK Najjar","year":"2024","unstructured":"Najjar, M. K., Khan, M. S., Zhuang, C., Chandra, A. & Lo, H.-W. Interleukin-1 receptor-associated kinase 1 in cancer metastasis and therapeutic resistance: mechanistic insights and translational advances. Cells 13, 1690 (2024).","journal-title":"Cells"},{"key":"1643_CR56","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1369\/0022155417742147","volume":"66","author":"P O\u2019Callaghan","year":"2018","unstructured":"O\u2019Callaghan, P., Zhang, X. & Li, J. P. Heparan sulfate proteoglycans as relays of neuroinflammation. J. Histochem. Cytochem. 66, 305\u2013319 (2018).","journal-title":"J. Histochem. Cytochem."},{"key":"1643_CR57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/1721727X15619185","volume":"13","author":"SH Park","year":"2015","unstructured":"Park, S. H., Choi, H.-J., Lee, S. Y. & Han, J.-S. TLR4-mediated IRAK1 activation induces TNF-\u03b1 expression via JNK-dependent NF-\u03baB activation in human bronchial epithelial cells. Eur. J. Inflamm. 13, 183\u2013195 (2015).","journal-title":"Eur. J. Inflamm."},{"key":"1643_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","volume":"17","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy 17, 1\u2013382 (2021).","journal-title":"Autophagy"},{"key":"1643_CR59","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s11011-018-0214-6","volume":"33","author":"K Pierzynowska","year":"2018","unstructured":"Pierzynowska, K. et al. Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases. Metab. Brain Dis. 33, 989\u20131008 (2018).","journal-title":"Metab. Brain Dis."},{"key":"1643_CR60","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3389\/fphar.2020.01225","volume":"11","author":"C Iside","year":"2020","unstructured":"Iside, C., Scafuro, M., Nebbioso, A. & Altucci, L. SIRT1 activation by natural phytochemicals: an overview. Front. Pharmacol. 11, 1225 (2020).","journal-title":"Front. Pharmacol."},{"key":"1643_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42431-4","volume":"13","author":"R Petrova","year":"2023","unstructured":"Petrova, R. et al. Disease pathology signatures in a mouse model of mucopolysaccharidosis type IIIB. Sci. Rep. 13, 16699 (2023).","journal-title":"Sci. Rep."},{"key":"1643_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109435","volume":"121","author":"S Menegas","year":"2023","unstructured":"Menegas, S. et al. Potential mechanisms of action of resveratrol in prevention and therapy for mental disorders. J. Nutr. Biochem. 121, 109435 (2023).","journal-title":"J. Nutr. Biochem."},{"key":"1643_CR63","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1080\/09168451.2020.1794783","volume":"84","author":"S Hidema","year":"2020","unstructured":"Hidema, S. et al. Single administration of resveratrol improves social behavior in adult mouse models of autism spectrum disorder. Biosci. Biotechnol. Biochem. 84, 2207\u20132214 (2020).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"1643_CR64","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neuro.2023.03.003","volume":"96","author":"SSV Shahrbabaki","year":"2023","unstructured":"Shahrbabaki, S. S. V. et al. Ameliorating age-dependent effects of resveratrol on VPA-induced social impairments and anxiety-like behaviors in a rat model of neurodevelopmental disorder. Neurotoxicology 96, 154\u2013165 (2023).","journal-title":"Neurotoxicology"},{"key":"1643_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2020.106905","volume":"81","author":"KB Juybari","year":"2020","unstructured":"Juybari, K. B. et al. Sex dependent alterations of resveratrol on social behaviors and nociceptive reactivity in VPA-induced autistic-like model in rats. Neurotoxicol. Teratol. 81, 106905 (2020).","journal-title":"Neurotoxicol. Teratol."},{"key":"1643_CR66","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.3390\/biomedicines10123107","volume":"10","author":"F Murgia","year":"2022","unstructured":"Murgia, F. et al. L. Sex hormones as key modulators of the immune response in multiple sclerosis: a review. Biomedicines 10, 3107 (2022).","journal-title":"Biomedicines"},{"key":"1643_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115737","volume":"215","author":"SR Bernstein","year":"2023","unstructured":"Bernstein, S. R., Kelleher, C. & Khalil, R. A. Gender-based research underscores sex differences in biological processes, clinical disorders and pharmacological interventions. Biochem. Pharmacol. 215, 115737 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"1643_CR68","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13293-024-00660-w","volume":"15","author":"SN Alexander","year":"2024","unstructured":"Alexander, S. N. et al. The influence of sex on neuroimmune communication, pain, and physiology. Biol. Sex Differ. 15, 82 (2024).","journal-title":"Biol. Sex Differ."},{"key":"1643_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2022.151232","volume":"101","author":"K Pierzynowska","year":"2022","unstructured":"Pierzynowska, K., \u017babi\u0144ska, M., Gaffke, L., Cyske, Z. & W\u0119grzyn, G. Changes in expression of signal transduction-related genes, and formation of aggregates of GPER1 and OXTR receptors in mucopolysaccharidosis cells. Eur. J. Cell Biol. 101, 151232 (2022).","journal-title":"Eur. J. Cell Biol."},{"key":"1643_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0223-0","volume":"12","author":"HH Chow","year":"2014","unstructured":"Chow, H. H. et al. A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones. J. Transl. Med. 12, 223 (2014).","journal-title":"J. Transl. Med."},{"key":"1643_CR71","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/10408444.2020.1762538","volume":"50","author":"RJ Qasem","year":"2020","unstructured":"Qasem, R. J. The estrogenic activity of resveratrol: a comprehensive review of in vitro and in vivo evidence and the potential for endocrine disruption. Crit. Rev. Toxicol. 50, 439\u2013462 (2020).","journal-title":"Crit. Rev. Toxicol."},{"key":"1643_CR72","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/ijms25021113","volume":"25","author":"Y Ago","year":"2024","unstructured":"Ago, Y., Rintz, E., Musini, K. S., Ma, Z. & Tomatsu, S. Molecular mechanisms in pathophysiology of mucopolysaccharidosis and prospects for innovative therapy. Int. J. Mol. Sci. 25, 1113 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1643_CR73","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3390\/ijms23041999","volume":"23","author":"O Mandolfo","year":"2022","unstructured":"Mandolfo, O., Parker, H. & Bigger, B. Innate immunity in mucopolysaccharide diseases. Int. J. Mol. Sci. 23, 1999 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1643_CR74","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ymgme.2016.01.012","volume":"117","author":"LE Polgreen","year":"2016","unstructured":"Polgreen, L. E. et al. Elevated TNF-\u03b1 is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI. Mol. Genet. Metab. 117, 427\u2013430 (2016).","journal-title":"Mol. Genet. Metab."},{"key":"1643_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12833","volume":"48","author":"AM Ludlaim","year":"2025","unstructured":"Ludlaim, A. M., Waddington, S. N. & McKay, T. R. Unifying biology of neurodegeneration in lysosomal storage diseases. J. Inherit. Metab. Dis. 48, e12833 (2025).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1643_CR76","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbrc.2023.04.093","volume":"665","author":"L Gaffke","year":"2023","unstructured":"Gaffke, L., Pierzynowska, K., Cyske, Z., Podlacha, M. & W\u0119grzyn, G. Contribution of vesicle trafficking dysregulation to the pathomechanism of mucopolysaccharidosis. Biochem. Biophys. Res. Commun. 665, 107\u2013117 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1643_CR77","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/ijms21041204","volume":"21","author":"L Gaffke","year":"2020","unstructured":"Gaffke, L. et al. Underestimated aspect of mucopolysaccharidosis pathogenesis: global changes in cellular processes revealed by transcriptomic studies. Int. J. Mol. Sci. 21, 1204 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1643_CR78","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/genes13040593","volume":"13","author":"Z Cyske","year":"2022","unstructured":"Cyske, Z., Gaffke, L., Pierzynowska, K. & W\u0119grzyn, G. Complex changes in the efficiency of the expression of many genes in monogenic diseases, mucopolysaccharidoses, may arise from significant disturbances in the levels of factors involved in the gene expression regulation processes. Genes 13, 593 (2022).","journal-title":"Genes"},{"key":"1643_CR79","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuint.2017.05.013","volume":"117","author":"C Vidoni","year":"2018","unstructured":"Vidoni, C., Secomandi, E., Castiglioni, A., Melone, M. & Isidoro, C. Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation. Neurochem. Int. 117, 174\u2013187 (2018).","journal-title":"Neurochem. Int."},{"key":"1643_CR80","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.bbapap.2017.02.014","volume":"1865","author":"S Gautam","year":"2017","unstructured":"Gautam, S. et al. Polyphenols in combination with \u03b2-cyclodextrin can inhibit and disaggregate \u03b1-synuclein amyloids under cell mimicking conditions: a promising therapeutic alternative. Biochim. Biophys. Acta Proteins Proteomics 1865, 589\u2013603 (2017).","journal-title":"Biochim. Biophys. Acta Proteins Proteomics"},{"key":"1643_CR81","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8152373","volume":"30","author":"B Gomes","year":"2018","unstructured":"Gomes, B. et al. Neuroprotective mechanisms of resveratrol in Alzheimer\u2019s disease: role of SIRT1. Oxid Med Cell Longev 30, 8152373 (2018).","journal-title":"Oxid Med Cell Longev"},{"key":"1643_CR82","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1371\/journal.pone.0000772","volume":"2","author":"CD Heldermon","year":"2007","unstructured":"Heldermon, C. D. et al. Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B. PLoS ONE 2, e772 (2007).","journal-title":"PLoS ONE"},{"key":"1643_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23903-5","volume":"12","author":"M De Risi","year":"2021","unstructured":"De Risi, M. et al. Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders. Nat. Commun 12, 3495 (2021).","journal-title":"Nat. Commun"},{"key":"1643_CR84","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.3390\/ijms21093194","volume":"21","author":"E Rintz","year":"2020","unstructured":"Rintz, E. et al. Transcriptomic changes related to cellular processes with particular emphasis on cell activation in lysosomal storage diseases from the group of mucopolysaccharidoses. Int. J. Mol. Sci. 21, 3194 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1643_CR85","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s11011-020-00614-2","volume":"35","author":"L Gaffke","year":"2020","unstructured":"Gaffke, L., Pierzynowska, K., Krzelowska, K., Piotrowska, E. & W\u0119grzyn, G. Changes in expressions of genes involved in the regulation of cellular processes in mucopolysaccharidoses as assessed by fibroblast culture-based transcriptomic analyses. Metab. Brain Dis. 35, 1353\u20131360 (2020).","journal-title":"Metab. Brain Dis."},{"key":"1643_CR86","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.3390\/ijms22052766","volume":"22","author":"L Gaffke","year":"2021","unstructured":"Gaffke, L. et al. Gene expression-related changes in morphologies of organelles and cellular component organization in mucopolysaccharidoses. Int. J. Mol. Sci. 22, 2766 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1643_CR87","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","volume":"85","author":"RS Turner","year":"2015","unstructured":"Turner, R. S. et al. Alzheimer\u2019s disease cooperative study. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85, 1383\u20131391 (2015).","journal-title":"Neurology"},{"key":"1643_CR88","doi-asserted-by":"publisher","first-page":"11676","DOI":"10.1021\/acs.jafc.1c02898","volume":"69","author":"R Shimazu","year":"2021","unstructured":"Shimazu, R., Anada, M., Miyaguchi, A., Nomi, Y. & Matsumoto, H. Evaluation of blood\u2013brain barrier permeability of polyphenols, anthocyanins, and their metabolites. J. Agric. Food Chem. 69, 11676\u201311686 (2021).","journal-title":"J. Agric. Food Chem."},{"key":"1643_CR89","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3389\/fphar.2018.01261","volume":"9","author":"S Andrade","year":"2018","unstructured":"Andrade, S., Ramalho, M. J., Pereira, M. D. C. & Loureiro, J. A. Resveratrol brain delivery for neurological disorders prevention and treatment. Front. Pharmacol. 9, 1261, (2018).","journal-title":"Front. Pharmacol."},{"key":"1643_CR90","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/10837450.2019.1680690","volume":"25","author":"R Katekar","year":"2020","unstructured":"Katekar, R. et al. Pharmacokinetics and brain targeting of trans-resveratrol loaded mixed micelles in rats following intravenous administration. Pharm. Dev. Technol. 25, 300\u2013307, (2020).","journal-title":"Pharm. Dev. Technol."},{"key":"1643_CR91","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2018.1556946","author":"JW Lee","year":"2019","unstructured":"Lee, J. W. et al. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia. Autophagy. https:\/\/doi.org\/10.1080\/15548627.2018.1556946 (2019).","journal-title":"Autophagy."}],"updated-by":[{"DOI":"10.1038\/s12276-026-01694-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000}}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01643-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01643-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01643-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:03:20Z","timestamp":1773839000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01643-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":91,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1643"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01643-0","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Modifications have been made to Figs. 5 and 8. Full Information regarding the corrections made can be found in the erratum\/correction for this article.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s12276-026-01694-3","URL":"https:\/\/doi.org\/10.1038\/s12276-026-01694-3","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}